nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Dysphagia—Mesalazine—Crohn's disease	0.00172	0.00203	CcSEcCtD
Tramadol—Anorexia—Mercaptopurine—Crohn's disease	0.00172	0.00202	CcSEcCtD
Tramadol—Pneumonia—Azathioprine—Crohn's disease	0.0017	0.002	CcSEcCtD
Tramadol—Bronchospasm—Mesalazine—Crohn's disease	0.0017	0.00199	CcSEcCtD
Tramadol—Delirium—Prednisone—Crohn's disease	0.00169	0.00199	CcSEcCtD
Tramadol—Pancreatitis—Mesalazine—Crohn's disease	0.00169	0.00199	CcSEcCtD
Tramadol—Infestation NOS—Azathioprine—Crohn's disease	0.00169	0.00198	CcSEcCtD
Tramadol—Infestation—Azathioprine—Crohn's disease	0.00169	0.00198	CcSEcCtD
Tramadol—Angina pectoris—Mesalazine—Crohn's disease	0.00168	0.00197	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00167	0.00197	CcSEcCtD
Tramadol—Contusion—Prednisone—Crohn's disease	0.00167	0.00196	CcSEcCtD
Tramadol—Bronchitis—Mesalazine—Crohn's disease	0.00166	0.00195	CcSEcCtD
Tramadol—Abdominal discomfort—Mesalazine—Crohn's disease	0.00165	0.00194	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00165	0.00193	CcSEcCtD
Tramadol—Dysuria—Mesalazine—Crohn's disease	0.00161	0.0019	CcSEcCtD
Tramadol—Viral infection—Prednisone—Crohn's disease	0.00161	0.00189	CcSEcCtD
Tramadol—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.0016	0.00188	CcSEcCtD
Tramadol—Arthropathy—Prednisone—Crohn's disease	0.0016	0.00188	CcSEcCtD
Tramadol—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0016	0.00188	CcSEcCtD
Tramadol—Pollakiuria—Mesalazine—Crohn's disease	0.00159	0.00187	CcSEcCtD
Tramadol—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00157	0.00185	CcSEcCtD
Tramadol—Decreased appetite—Mercaptopurine—Crohn's disease	0.00157	0.00185	CcSEcCtD
Tramadol—Weight decreased—Mesalazine—Crohn's disease	0.00156	0.00183	CcSEcCtD
Tramadol—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00156	0.00183	CcSEcCtD
Tramadol—Pneumonia—Mesalazine—Crohn's disease	0.00155	0.00182	CcSEcCtD
Tramadol—Infestation NOS—Mesalazine—Crohn's disease	0.00154	0.00181	CcSEcCtD
Tramadol—Infestation—Mesalazine—Crohn's disease	0.00154	0.00181	CcSEcCtD
Tramadol—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00154	0.00181	CcSEcCtD
Tramadol—Depression—Mesalazine—Crohn's disease	0.00153	0.0018	CcSEcCtD
Tramadol—Cataract—Prednisone—Crohn's disease	0.00153	0.0018	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00152	0.00179	CcSEcCtD
Tramadol—Haemoglobin—Azathioprine—Crohn's disease	0.00152	0.00179	CcSEcCtD
Tramadol—Haemorrhage—Azathioprine—Crohn's disease	0.00151	0.00178	CcSEcCtD
Tramadol—Renal failure—Mesalazine—Crohn's disease	0.00151	0.00178	CcSEcCtD
Tramadol—Stomatitis—Mesalazine—Crohn's disease	0.0015	0.00176	CcSEcCtD
Tramadol—Conjunctivitis—Mesalazine—Crohn's disease	0.00149	0.00176	CcSEcCtD
Tramadol—Urinary tract infection—Mesalazine—Crohn's disease	0.00149	0.00176	CcSEcCtD
Tramadol—Sweating—Mesalazine—Crohn's disease	0.00147	0.00173	CcSEcCtD
Tramadol—Haematuria—Mesalazine—Crohn's disease	0.00147	0.00172	CcSEcCtD
Tramadol—Hiccups—Prednisone—Crohn's disease	0.00145	0.00171	CcSEcCtD
Tramadol—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00145	0.00171	CcSEcCtD
Tramadol—Epistaxis—Mesalazine—Crohn's disease	0.00145	0.0017	CcSEcCtD
Tramadol—Sinusitis—Mesalazine—Crohn's disease	0.00144	0.0017	CcSEcCtD
Tramadol—Erythema multiforme—Azathioprine—Crohn's disease	0.00143	0.00168	CcSEcCtD
Tramadol—Body temperature increased—Mercaptopurine—Crohn's disease	0.00143	0.00168	CcSEcCtD
Tramadol—Haemoglobin—Mesalazine—Crohn's disease	0.00139	0.00163	CcSEcCtD
Tramadol—Rhinitis—Mesalazine—Crohn's disease	0.00138	0.00163	CcSEcCtD
Tramadol—Haemorrhage—Mesalazine—Crohn's disease	0.00138	0.00162	CcSEcCtD
Tramadol—Hepatitis—Mesalazine—Crohn's disease	0.00138	0.00162	CcSEcCtD
Tramadol—Pharyngitis—Mesalazine—Crohn's disease	0.00137	0.00161	CcSEcCtD
Tramadol—Immune system disorder—Azathioprine—Crohn's disease	0.00137	0.00161	CcSEcCtD
Tramadol—Mediastinal disorder—Azathioprine—Crohn's disease	0.00137	0.0016	CcSEcCtD
Tramadol—Urinary tract disorder—Mesalazine—Crohn's disease	0.00136	0.0016	CcSEcCtD
Tramadol—Oedema peripheral—Mesalazine—Crohn's disease	0.00136	0.0016	CcSEcCtD
Tramadol—Chills—Azathioprine—Crohn's disease	0.00136	0.0016	CcSEcCtD
Tramadol—Connective tissue disorder—Mesalazine—Crohn's disease	0.00136	0.00159	CcSEcCtD
Tramadol—Arrhythmia—Azathioprine—Crohn's disease	0.00135	0.00159	CcSEcCtD
Tramadol—Urethral disorder—Mesalazine—Crohn's disease	0.00135	0.00159	CcSEcCtD
Tramadol—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00133	0.00156	CcSEcCtD
Tramadol—Ecchymosis—Prednisone—Crohn's disease	0.00131	0.00155	CcSEcCtD
Tramadol—Erythema multiforme—Mesalazine—Crohn's disease	0.0013	0.00153	CcSEcCtD
Tramadol—Pulmonary oedema—Prednisone—Crohn's disease	0.00129	0.00152	CcSEcCtD
Tramadol—Eye disorder—Mesalazine—Crohn's disease	0.00129	0.00152	CcSEcCtD
Tramadol—Tinnitus—Mesalazine—Crohn's disease	0.00129	0.00151	CcSEcCtD
Tramadol—Cardiac disorder—Mesalazine—Crohn's disease	0.00128	0.00151	CcSEcCtD
Tramadol—Hyperkinesia—Prednisone—Crohn's disease	0.00127	0.00149	CcSEcCtD
Tramadol—Angiopathy—Mesalazine—Crohn's disease	0.00125	0.00147	CcSEcCtD
Tramadol—Euphoric mood—Prednisone—Crohn's disease	0.00125	0.00147	CcSEcCtD
Tramadol—Immune system disorder—Mesalazine—Crohn's disease	0.00125	0.00147	CcSEcCtD
Tramadol—Mediastinal disorder—Mesalazine—Crohn's disease	0.00124	0.00146	CcSEcCtD
Tramadol—Chills—Mesalazine—Crohn's disease	0.00124	0.00146	CcSEcCtD
Tramadol—Diarrhoea—Mercaptopurine—Crohn's disease	0.00124	0.00145	CcSEcCtD
Tramadol—Ill-defined disorder—Azathioprine—Crohn's disease	0.00122	0.00144	CcSEcCtD
Tramadol—Anaemia—Azathioprine—Crohn's disease	0.00122	0.00143	CcSEcCtD
Tramadol—Diabetes mellitus—Prednisone—Crohn's disease	0.00121	0.00143	CcSEcCtD
Tramadol—Mental disorder—Mesalazine—Crohn's disease	0.00121	0.00142	CcSEcCtD
Tramadol—Erythema—Mesalazine—Crohn's disease	0.0012	0.00141	CcSEcCtD
Tramadol—Malaise—Azathioprine—Crohn's disease	0.00119	0.0014	CcSEcCtD
Tramadol—Flatulence—Mesalazine—Crohn's disease	0.00118	0.00139	CcSEcCtD
Tramadol—Vascular purpura—Prednisone—Crohn's disease	0.00118	0.00139	CcSEcCtD
Tramadol—Tension—Mesalazine—Crohn's disease	0.00118	0.00139	CcSEcCtD
Tramadol—Dysgeusia—Mesalazine—Crohn's disease	0.00118	0.00138	CcSEcCtD
Tramadol—Nervousness—Mesalazine—Crohn's disease	0.00117	0.00137	CcSEcCtD
Tramadol—Back pain—Mesalazine—Crohn's disease	0.00116	0.00137	CcSEcCtD
Tramadol—Muscle spasms—Mesalazine—Crohn's disease	0.00115	0.00136	CcSEcCtD
Tramadol—Vomiting—Mercaptopurine—Crohn's disease	0.00115	0.00135	CcSEcCtD
Tramadol—Injury—Prednisone—Crohn's disease	0.00115	0.00135	CcSEcCtD
Tramadol—Rash—Mercaptopurine—Crohn's disease	0.00114	0.00134	CcSEcCtD
Tramadol—Dermatitis—Mercaptopurine—Crohn's disease	0.00114	0.00134	CcSEcCtD
Tramadol—Vision blurred—Mesalazine—Crohn's disease	0.00113	0.00133	CcSEcCtD
Tramadol—Tremor—Mesalazine—Crohn's disease	0.00113	0.00132	CcSEcCtD
Tramadol—Increased appetite—Prednisone—Crohn's disease	0.00112	0.00132	CcSEcCtD
Tramadol—Amnesia—Prednisone—Crohn's disease	0.00112	0.00132	CcSEcCtD
Tramadol—Myalgia—Azathioprine—Crohn's disease	0.00112	0.00132	CcSEcCtD
Tramadol—Arthralgia—Azathioprine—Crohn's disease	0.00112	0.00132	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00111	0.00131	CcSEcCtD
Tramadol—Ill-defined disorder—Mesalazine—Crohn's disease	0.00111	0.00131	CcSEcCtD
Tramadol—Anaemia—Mesalazine—Crohn's disease	0.00111	0.00131	CcSEcCtD
Tramadol—Discomfort—Azathioprine—Crohn's disease	0.00111	0.0013	CcSEcCtD
Tramadol—Angioedema—Mesalazine—Crohn's disease	0.0011	0.00129	CcSEcCtD
Tramadol—Purpura—Prednisone—Crohn's disease	0.00109	0.00129	CcSEcCtD
Tramadol—Malaise—Mesalazine—Crohn's disease	0.00108	0.00127	CcSEcCtD
Tramadol—Vertigo—Mesalazine—Crohn's disease	0.00108	0.00127	CcSEcCtD
Tramadol—Syncope—Mesalazine—Crohn's disease	0.00108	0.00127	CcSEcCtD
Tramadol—Lethargy—Prednisone—Crohn's disease	0.00108	0.00127	CcSEcCtD
Tramadol—Nausea—Mercaptopurine—Crohn's disease	0.00107	0.00126	CcSEcCtD
Tramadol—Infection—Azathioprine—Crohn's disease	0.00107	0.00126	CcSEcCtD
Tramadol—Palpitations—Mesalazine—Crohn's disease	0.00106	0.00125	CcSEcCtD
Tramadol—Loss of consciousness—Mesalazine—Crohn's disease	0.00106	0.00124	CcSEcCtD
Tramadol—Osteoarthritis—Prednisone—Crohn's disease	0.00106	0.00124	CcSEcCtD
Tramadol—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.00106	0.00124	CcSEcCtD
Tramadol—Thrombocytopenia—Azathioprine—Crohn's disease	0.00105	0.00124	CcSEcCtD
Tramadol—Cough—Mesalazine—Crohn's disease	0.00105	0.00123	CcSEcCtD
Tramadol—Skin disorder—Azathioprine—Crohn's disease	0.00105	0.00123	CcSEcCtD
Tramadol—Affect lability—Prednisone—Crohn's disease	0.00104	0.00122	CcSEcCtD
Tramadol—Hypertension—Mesalazine—Crohn's disease	0.00104	0.00122	CcSEcCtD
Tramadol—Psychotic disorder—Prednisone—Crohn's disease	0.00103	0.00121	CcSEcCtD
Tramadol—Chest pain—Mesalazine—Crohn's disease	0.00102	0.0012	CcSEcCtD
Tramadol—Arthralgia—Mesalazine—Crohn's disease	0.00102	0.0012	CcSEcCtD
Tramadol—Myalgia—Mesalazine—Crohn's disease	0.00102	0.0012	CcSEcCtD
Tramadol—Anxiety—Mesalazine—Crohn's disease	0.00102	0.0012	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00102	0.00119	CcSEcCtD
Tramadol—Discomfort—Mesalazine—Crohn's disease	0.00101	0.00119	CcSEcCtD
Tramadol—Irritability—Prednisone—Crohn's disease	0.00101	0.00118	CcSEcCtD
Tramadol—Hypotension—Azathioprine—Crohn's disease	0.00101	0.00118	CcSEcCtD
Tramadol—Dry mouth—Mesalazine—Crohn's disease	0.001	0.00118	CcSEcCtD
Tramadol—Mood swings—Prednisone—Crohn's disease	0.001	0.00118	CcSEcCtD
Tramadol—Confusional state—Mesalazine—Crohn's disease	0.000989	0.00116	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000981	0.00115	CcSEcCtD
Tramadol—Anaphylactic shock—Mesalazine—Crohn's disease	0.00098	0.00115	CcSEcCtD
Tramadol—Infection—Mesalazine—Crohn's disease	0.000974	0.00114	CcSEcCtD
Tramadol—Dry skin—Prednisone—Crohn's disease	0.000967	0.00114	CcSEcCtD
Tramadol—Shock—Mesalazine—Crohn's disease	0.000965	0.00113	CcSEcCtD
Tramadol—Nervous system disorder—Mesalazine—Crohn's disease	0.000961	0.00113	CcSEcCtD
Tramadol—Hypokalaemia—Prednisone—Crohn's disease	0.00096	0.00113	CcSEcCtD
Tramadol—Thrombocytopenia—Mesalazine—Crohn's disease	0.00096	0.00113	CcSEcCtD
Tramadol—Tachycardia—Mesalazine—Crohn's disease	0.000957	0.00112	CcSEcCtD
Tramadol—Skin disorder—Mesalazine—Crohn's disease	0.000952	0.00112	CcSEcCtD
Tramadol—Hyperhidrosis—Mesalazine—Crohn's disease	0.000948	0.00111	CcSEcCtD
Tramadol—Anorexia—Mesalazine—Crohn's disease	0.000934	0.0011	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000931	0.00109	CcSEcCtD
Tramadol—Muscular weakness—Prednisone—Crohn's disease	0.000931	0.00109	CcSEcCtD
Tramadol—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000929	0.00109	CcSEcCtD
Tramadol—Abdominal distension—Prednisone—Crohn's disease	0.000918	0.00108	CcSEcCtD
Tramadol—Hypotension—Mesalazine—Crohn's disease	0.000916	0.00108	CcSEcCtD
Tramadol—Pancreatitis—Prednisone—Crohn's disease	0.000894	0.00105	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000893	0.00105	CcSEcCtD
Tramadol—Sweating increased—Prednisone—Crohn's disease	0.000889	0.00104	CcSEcCtD
Tramadol—Feeling abnormal—Azathioprine—Crohn's disease	0.000887	0.00104	CcSEcCtD
Tramadol—Insomnia—Mesalazine—Crohn's disease	0.000887	0.00104	CcSEcCtD
Tramadol—Paraesthesia—Mesalazine—Crohn's disease	0.00088	0.00103	CcSEcCtD
Tramadol—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00088	0.00103	CcSEcCtD
Tramadol—Dyspnoea—Mesalazine—Crohn's disease	0.000874	0.00103	CcSEcCtD
Tramadol—Somnolence—Mesalazine—Crohn's disease	0.000872	0.00102	CcSEcCtD
Tramadol—Dyspepsia—Mesalazine—Crohn's disease	0.000863	0.00101	CcSEcCtD
Tramadol—Decreased appetite—Mesalazine—Crohn's disease	0.000852	0.001	CcSEcCtD
Tramadol—Abdominal pain—Azathioprine—Crohn's disease	0.000851	0.001	CcSEcCtD
Tramadol—Body temperature increased—Azathioprine—Crohn's disease	0.000851	0.001	CcSEcCtD
Tramadol—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000846	0.000995	CcSEcCtD
Tramadol—Fatigue—Mesalazine—Crohn's disease	0.000845	0.000994	CcSEcCtD
Tramadol—Erectile dysfunction—Prednisone—Crohn's disease	0.00084	0.000988	CcSEcCtD
Tramadol—Pain—Mesalazine—Crohn's disease	0.000838	0.000985	CcSEcCtD
Tramadol—Constipation—Mesalazine—Crohn's disease	0.000838	0.000985	CcSEcCtD
Tramadol—Weight decreased—Prednisone—Crohn's disease	0.000825	0.00097	CcSEcCtD
Tramadol—Hyperglycaemia—Prednisone—Crohn's disease	0.000823	0.000967	CcSEcCtD
Tramadol—Depression—Prednisone—Crohn's disease	0.000811	0.000953	CcSEcCtD
Tramadol—Feeling abnormal—Mesalazine—Crohn's disease	0.000808	0.00095	CcSEcCtD
Tramadol—Acute coronary syndrome—Prednisone—Crohn's disease	0.000802	0.000942	CcSEcCtD
Tramadol—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000802	0.000942	CcSEcCtD
Tramadol—Myocardial infarction—Prednisone—Crohn's disease	0.000797	0.000937	CcSEcCtD
Tramadol—Hypersensitivity—Azathioprine—Crohn's disease	0.000793	0.000932	CcSEcCtD
Tramadol—Urticaria—Mesalazine—Crohn's disease	0.000779	0.000916	CcSEcCtD
Tramadol—Abdominal pain—Mesalazine—Crohn's disease	0.000775	0.000911	CcSEcCtD
Tramadol—Body temperature increased—Mesalazine—Crohn's disease	0.000775	0.000911	CcSEcCtD
Tramadol—Bradycardia—Prednisone—Crohn's disease	0.000743	0.000874	CcSEcCtD
Tramadol—Diarrhoea—Azathioprine—Crohn's disease	0.000736	0.000866	CcSEcCtD
Tramadol—Haemoglobin—Prednisone—Crohn's disease	0.000734	0.000863	CcSEcCtD
Tramadol—Haemorrhage—Prednisone—Crohn's disease	0.00073	0.000858	CcSEcCtD
Tramadol—Hallucination—Prednisone—Crohn's disease	0.000726	0.000854	CcSEcCtD
Tramadol—Hypersensitivity—Mesalazine—Crohn's disease	0.000722	0.000849	CcSEcCtD
Tramadol—Connective tissue disorder—Prednisone—Crohn's disease	0.000717	0.000843	CcSEcCtD
Tramadol—Dizziness—Azathioprine—Crohn's disease	0.000712	0.000837	CcSEcCtD
Tramadol—Asthenia—Mesalazine—Crohn's disease	0.000703	0.000827	CcSEcCtD
Tramadol—Pruritus—Mesalazine—Crohn's disease	0.000694	0.000815	CcSEcCtD
Tramadol—Vomiting—Azathioprine—Crohn's disease	0.000684	0.000804	CcSEcCtD
Tramadol—Eye disorder—Prednisone—Crohn's disease	0.000682	0.000802	CcSEcCtD
Tramadol—Rash—Azathioprine—Crohn's disease	0.000679	0.000798	CcSEcCtD
Tramadol—Dermatitis—Azathioprine—Crohn's disease	0.000678	0.000797	CcSEcCtD
Tramadol—Flushing—Prednisone—Crohn's disease	0.000678	0.000797	CcSEcCtD
Tramadol—Headache—Azathioprine—Crohn's disease	0.000674	0.000793	CcSEcCtD
Tramadol—Diarrhoea—Mesalazine—Crohn's disease	0.000671	0.000789	CcSEcCtD
Tramadol—Angiopathy—Prednisone—Crohn's disease	0.000662	0.000779	CcSEcCtD
Tramadol—Immune system disorder—Prednisone—Crohn's disease	0.000659	0.000775	CcSEcCtD
Tramadol—Arrhythmia—Prednisone—Crohn's disease	0.000652	0.000767	CcSEcCtD
Tramadol—Dizziness—Mesalazine—Crohn's disease	0.000648	0.000762	CcSEcCtD
Tramadol—Mental disorder—Prednisone—Crohn's disease	0.00064	0.000752	CcSEcCtD
Tramadol—Nausea—Azathioprine—Crohn's disease	0.000639	0.000752	CcSEcCtD
Tramadol—Erythema—Prednisone—Crohn's disease	0.000636	0.000747	CcSEcCtD
Tramadol—Malnutrition—Prednisone—Crohn's disease	0.000636	0.000747	CcSEcCtD
Tramadol—Vomiting—Mesalazine—Crohn's disease	0.000623	0.000733	CcSEcCtD
Tramadol—Rash—Mesalazine—Crohn's disease	0.000618	0.000727	CcSEcCtD
Tramadol—Dermatitis—Mesalazine—Crohn's disease	0.000618	0.000726	CcSEcCtD
Tramadol—Headache—Mesalazine—Crohn's disease	0.000614	0.000722	CcSEcCtD
Tramadol—Vision blurred—Prednisone—Crohn's disease	0.000599	0.000704	CcSEcCtD
Tramadol—Ill-defined disorder—Prednisone—Crohn's disease	0.00059	0.000693	CcSEcCtD
Tramadol—Anaemia—Prednisone—Crohn's disease	0.000587	0.000691	CcSEcCtD
Tramadol—Agitation—Prednisone—Crohn's disease	0.000584	0.000687	CcSEcCtD
Tramadol—Nausea—Mesalazine—Crohn's disease	0.000582	0.000685	CcSEcCtD
Tramadol—Angioedema—Prednisone—Crohn's disease	0.000581	0.000683	CcSEcCtD
Tramadol—Malaise—Prednisone—Crohn's disease	0.000573	0.000674	CcSEcCtD
Tramadol—Vertigo—Prednisone—Crohn's disease	0.000571	0.000671	CcSEcCtD
Tramadol—Syncope—Prednisone—Crohn's disease	0.00057	0.00067	CcSEcCtD
Tramadol—Loss of consciousness—Prednisone—Crohn's disease	0.000559	0.000657	CcSEcCtD
Tramadol—Convulsion—Prednisone—Crohn's disease	0.000551	0.000647	CcSEcCtD
Tramadol—Hypertension—Prednisone—Crohn's disease	0.000549	0.000645	CcSEcCtD
Tramadol—Myalgia—Prednisone—Crohn's disease	0.000541	0.000636	CcSEcCtD
Tramadol—Arthralgia—Prednisone—Crohn's disease	0.000541	0.000636	CcSEcCtD
Tramadol—Anxiety—Prednisone—Crohn's disease	0.000539	0.000634	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000537	0.000632	CcSEcCtD
Tramadol—Discomfort—Prednisone—Crohn's disease	0.000535	0.000628	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisone—Crohn's disease	0.000519	0.00061	CcSEcCtD
Tramadol—Infection—Prednisone—Crohn's disease	0.000515	0.000606	CcSEcCtD
Tramadol—Shock—Prednisone—Crohn's disease	0.00051	0.0006	CcSEcCtD
Tramadol—Nervous system disorder—Prednisone—Crohn's disease	0.000509	0.000598	CcSEcCtD
Tramadol—Tachycardia—Prednisone—Crohn's disease	0.000506	0.000595	CcSEcCtD
Tramadol—Skin disorder—Prednisone—Crohn's disease	0.000504	0.000592	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisone—Crohn's disease	0.000501	0.000589	CcSEcCtD
Tramadol—Anorexia—Prednisone—Crohn's disease	0.000494	0.000581	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000473	0.000556	CcSEcCtD
Tramadol—Insomnia—Prednisone—Crohn's disease	0.000469	0.000551	CcSEcCtD
Tramadol—Paraesthesia—Prednisone—Crohn's disease	0.000466	0.000548	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—Crohn's disease	0.000457	0.000537	CcSEcCtD
Tramadol—Decreased appetite—Prednisone—Crohn's disease	0.000451	0.00053	CcSEcCtD
Tramadol—Fatigue—Prednisone—Crohn's disease	0.000447	0.000526	CcSEcCtD
Tramadol—Constipation—Prednisone—Crohn's disease	0.000444	0.000521	CcSEcCtD
Tramadol—Feeling abnormal—Prednisone—Crohn's disease	0.000427	0.000502	CcSEcCtD
Tramadol—Gastrointestinal pain—Prednisone—Crohn's disease	0.000424	0.000499	CcSEcCtD
Tramadol—Urticaria—Prednisone—Crohn's disease	0.000412	0.000484	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—Crohn's disease	0.00041	0.000482	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—Crohn's disease	0.00041	0.000482	CcSEcCtD
Tramadol—Hypersensitivity—Prednisone—Crohn's disease	0.000382	0.000449	CcSEcCtD
Tramadol—Asthenia—Prednisone—Crohn's disease	0.000372	0.000437	CcSEcCtD
Tramadol—Pruritus—Prednisone—Crohn's disease	0.000367	0.000431	CcSEcCtD
Tramadol—Diarrhoea—Prednisone—Crohn's disease	0.000355	0.000417	CcSEcCtD
Tramadol—Dizziness—Prednisone—Crohn's disease	0.000343	0.000403	CcSEcCtD
Tramadol—Vomiting—Prednisone—Crohn's disease	0.00033	0.000388	CcSEcCtD
Tramadol—Rash—Prednisone—Crohn's disease	0.000327	0.000384	CcSEcCtD
Tramadol—Dermatitis—Prednisone—Crohn's disease	0.000327	0.000384	CcSEcCtD
Tramadol—Headache—Prednisone—Crohn's disease	0.000325	0.000382	CcSEcCtD
Tramadol—Nausea—Prednisone—Crohn's disease	0.000308	0.000362	CcSEcCtD
Tramadol—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000226	0.00151	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.000224	0.0015	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CCR9—Crohn's disease	0.000222	0.00148	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000218	0.00146	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000217	0.00145	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000216	0.00145	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.000215	0.00144	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000211	0.00141	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000209	0.0014	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GPR65—Crohn's disease	0.000206	0.00138	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000204	0.00137	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000203	0.00136	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000202	0.00135	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCR9—Crohn's disease	0.000201	0.00135	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.0002	0.00134	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.000197	0.00132	CbGpPWpGaD
Tramadol—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000195	0.00131	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000193	0.00129	CbGpPWpGaD
Tramadol—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000191	0.00128	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.000191	0.00128	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00019	0.00128	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000189	0.00127	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GPR65—Crohn's disease	0.000187	0.00125	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000187	0.00125	CbGpPWpGaD
Tramadol—SLC6A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000186	0.00125	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000184	0.00124	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000184	0.00123	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000183	0.00122	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ACKR2—Crohn's disease	0.000181	0.00121	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.000179	0.0012	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000178	0.00119	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.000177	0.00119	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000174	0.00116	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.000173	0.00116	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000173	0.00116	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000173	0.00116	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MLN—Crohn's disease	0.000171	0.00115	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000171	0.00114	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00017	0.00114	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000167	0.00112	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000164	0.0011	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000163	0.00109	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000162	0.00108	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.000162	0.00108	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000161	0.00108	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000161	0.00108	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00016	0.00107	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000157	0.00105	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TAGAP—Crohn's disease	0.000157	0.00105	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000156	0.00104	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000155	0.00104	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000155	0.00104	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000152	0.00102	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000152	0.00102	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000152	0.00102	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000151	0.00101	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000151	0.00101	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00015	0.00101	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000148	0.000989	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CCR6—Crohn's disease	0.000147	0.000983	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000147	0.000983	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000147	0.000982	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00014	0.000938	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	0.000139	0.000931	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000138	0.000927	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000138	0.000922	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTMR3—Crohn's disease	0.000137	0.00092	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RSPO3—Crohn's disease	0.000137	0.000918	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000137	0.000915	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000135	0.000904	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCR6—Crohn's disease	0.000133	0.000893	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000133	0.000892	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000132	0.000881	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SEL1L—Crohn's disease	0.00013	0.00087	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PTGER4—Crohn's disease	0.000129	0.000865	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000129	0.000862	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000128	0.000858	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000128	0.000857	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	0.000127	0.00085	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000126	0.000846	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000124	0.00083	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000124	0.000829	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000121	0.000811	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR9—Crohn's disease	0.000119	0.000796	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTMR3—Crohn's disease	0.000118	0.000791	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000118	0.000791	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	0.000117	0.000786	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000116	0.00078	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000115	0.000772	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000115	0.000769	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000113	0.000754	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000112	0.000749	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000112	0.000749	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000111	0.000745	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GPR65—Crohn's disease	0.000111	0.00074	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	0.00011	0.000737	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.00011	0.000737	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00011	0.000736	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000109	0.00073	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000108	0.000727	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—FADS1—Crohn's disease	0.000107	0.000717	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000106	0.000713	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000106	0.000712	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000102	0.000685	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000101	0.000677	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GPX4—Crohn's disease	0.0001	0.000671	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL3—Crohn's disease	0.0001	0.000669	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RBX1—Crohn's disease	9.81e-05	0.000657	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	9.81e-05	0.000657	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	9.75e-05	0.000653	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GCKR—Crohn's disease	9.68e-05	0.000648	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	9.67e-05	0.000647	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	9.66e-05	0.000647	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	9.65e-05	0.000646	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	9.55e-05	0.00064	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GPR65—Crohn's disease	9.51e-05	0.000637	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	9.51e-05	0.000637	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	9.48e-05	0.000635	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	9.47e-05	0.000634	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.46e-05	0.000634	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL3—Crohn's disease	9.28e-05	0.000621	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—FADS1—Crohn's disease	9.2e-05	0.000616	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR6—Crohn's disease	9.17e-05	0.000614	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	9.17e-05	0.000614	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	8.98e-05	0.000601	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	8.97e-05	0.000601	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX4—Crohn's disease	8.62e-05	0.000577	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL3—Crohn's disease	8.61e-05	0.000576	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	8.6e-05	0.000576	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	8.37e-05	0.000561	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	8.34e-05	0.000559	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.34e-05	0.000558	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	8.32e-05	0.000557	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GCKR—Crohn's disease	8.32e-05	0.000557	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RBX1—Crohn's disease	8.29e-05	0.000555	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTMR3—Crohn's disease	8.21e-05	0.00055	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	8.15e-05	0.000546	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	8.14e-05	0.000545	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL3—Crohn's disease	8.14e-05	0.000545	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	8.13e-05	0.000545	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	8.07e-05	0.000541	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR6—Crohn's disease	7.87e-05	0.000527	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	7.87e-05	0.000527	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	7.75e-05	0.000519	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	7.71e-05	0.000516	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	7.43e-05	0.000498	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	7.4e-05	0.000495	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	7.27e-05	0.000487	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	7.21e-05	0.000483	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	7.18e-05	0.000481	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	7.14e-05	0.000478	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	7.13e-05	0.000477	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RBX1—Crohn's disease	7.12e-05	0.000477	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	7.05e-05	0.000472	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	7.02e-05	0.00047	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	7e-05	0.000469	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	6.93e-05	0.000464	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL3—Crohn's disease	6.88e-05	0.000461	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	6.8e-05	0.000455	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR6—Crohn's disease	6.78e-05	0.000454	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	6.75e-05	0.000452	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	6.65e-05	0.000445	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	6.64e-05	0.000445	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	6.52e-05	0.000436	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	6.5e-05	0.000435	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	6.48e-05	0.000434	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—FADS1—Crohn's disease	6.4e-05	0.000428	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.31e-05	0.000423	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	6.24e-05	0.000418	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	6.16e-05	0.000412	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RBX1—Crohn's disease	6.13e-05	0.000411	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	6.06e-05	0.000406	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	6.04e-05	0.000404	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	6.03e-05	0.000404	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	6.03e-05	0.000404	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX4—Crohn's disease	5.99e-05	0.000401	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	5.97e-05	0.0004	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	5.92e-05	0.000396	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL3—Crohn's disease	5.9e-05	0.000395	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GCKR—Crohn's disease	5.79e-05	0.000387	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	5.75e-05	0.000385	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	5.71e-05	0.000382	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	5.7e-05	0.000382	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	5.51e-05	0.000369	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	5.48e-05	0.000367	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	5.38e-05	0.00036	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.37e-05	0.00036	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	5.21e-05	0.000349	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	5.2e-05	0.000348	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	5.18e-05	0.000347	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	5.17e-05	0.000347	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL3—Crohn's disease	5.08e-05	0.00034	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	5e-05	0.000335	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	4.93e-05	0.00033	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	4.92e-05	0.000329	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	4.82e-05	0.000323	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.73e-05	0.000317	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	4.71e-05	0.000315	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TYK2—Crohn's disease	4.58e-05	0.000307	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	4.47e-05	0.000299	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	4.46e-05	0.000299	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	4.45e-05	0.000298	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—JAK2—Crohn's disease	4.37e-05	0.000293	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	4.3e-05	0.000288	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	4.25e-05	0.000284	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—FADS1—Crohn's disease	4.18e-05	0.00028	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.14e-05	0.000277	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	4.07e-05	0.000273	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	4.05e-05	0.000271	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TYK2—Crohn's disease	4.02e-05	0.000269	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	3.99e-05	0.000267	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX4—Crohn's disease	3.92e-05	0.000262	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	3.85e-05	0.000258	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JAK2—Crohn's disease	3.83e-05	0.000257	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—Crohn's disease	3.79e-05	0.000254	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCKR—Crohn's disease	3.78e-05	0.000253	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	3.7e-05	0.000248	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	3.56e-05	0.000239	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	3.5e-05	0.000234	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TYK2—Crohn's disease	3.39e-05	0.000227	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—Crohn's disease	3.32e-05	0.000223	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JAK2—Crohn's disease	3.24e-05	0.000217	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—Crohn's disease	3.21e-05	0.000215	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—Crohn's disease	3.08e-05	0.000206	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	2.95e-05	0.000198	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TYK2—Crohn's disease	2.91e-05	0.000195	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—Crohn's disease	2.81e-05	0.000188	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—Crohn's disease	2.81e-05	0.000188	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JAK2—Crohn's disease	2.78e-05	0.000186	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—Crohn's disease	2.69e-05	0.00018	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—Crohn's disease	2.65e-05	0.000177	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	2.54e-05	0.00017	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TYK2—Crohn's disease	2.51e-05	0.000168	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.41e-05	0.000162	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JAK2—Crohn's disease	2.39e-05	0.00016	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—Crohn's disease	2.38e-05	0.000159	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—Crohn's disease	2.32e-05	0.000155	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—Crohn's disease	2.24e-05	0.00015	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	2.18e-05	0.000146	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—Crohn's disease	2.08e-05	0.000139	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.04e-05	0.000137	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—Crohn's disease	1.96e-05	0.000132	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—Crohn's disease	1.84e-05	0.000123	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—Crohn's disease	1.76e-05	0.000118	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—Crohn's disease	1.66e-05	0.000111	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.61e-05	0.000108	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.43e-05	9.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—Crohn's disease	1.23e-05	8.22e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—Crohn's disease	1.2e-05	8.06e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.05e-05	7.05e-05	CbGpPWpGaD
